Literature DB >> 23516282

Postnatal loss of P/Q-type channels confined to rhombic-lip-derived neurons alters synaptic transmission at the parallel fiber to purkinje cell synapse and replicates genomic Cacna1a mutation phenotype of ataxia and seizures in mice.

Takashi Maejima1, Patric Wollenweber, Lena U C Teusner, Jeffrey L Noebels, Stefan Herlitze, Melanie D Mark.   

Abstract

Ataxia, episodic dyskinesia, and thalamocortical seizures are associated with an inherited loss of P/Q-type voltage-gated Ca(2+) channel function. P/Q-type channels are widely expressed throughout the neuraxis, obscuring identification of the critical networks underlying these complex neurological disorders. We showed recently that the conditional postnatal loss of P/Q-type channels in cerebellar Purkinje cells (PCs) in mice (purky) leads to these aberrant phenotypes, suggesting that intrinsic alteration in PC output is a sufficient pathogenic factor for disease initiation. The question arises whether P/Q-type channel deletion confined to a single upstream cerebellar synapse might induce the pathophysiological abnormality of genomically inherited P/Q-type channel disorders. PCs integrate two excitatory inputs, climbing fibers from inferior olive and parallel fibers (PFs) from granule cells (GCs) that receive mossy fiber (MF) input derived from precerebellar nuclei. In this study, we introduce a new mouse model with a selective knock-out of P/Q-type channels in rhombic-lip-derived neurons including the PF and MF pathways (quirky). We found that in quirky mice, PF-PC synaptic transmission is reduced during low-frequency stimulation. Using focal light stimulation of GCs that express optogenetic light-sensitive channels, channelrhodopsin-2, we found that modulation of PC firing via GC input is reduced in quirky mice. Phenotypic analysis revealed that quirky mice display ataxia, dyskinesia, and absence epilepsy. These results suggest that developmental alteration of patterned input confined to only one of the main afferent cerebellar excitatory synaptic pathways has a significant role in generating the neurological phenotype associated with the global genomic loss of P/Q-type channel function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23516282      PMCID: PMC3641643          DOI: 10.1523/JNEUROSCI.5442-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

Review 1.  Activity-dependent maturation of climbing fiber to Purkinje cell synapses during postnatal cerebellar development.

Authors:  Masanobu Kano; Kouichi Hashimoto
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

2.  A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system.

Authors:  F A Edwards; A Konnerth; B Sakmann; T Takahashi
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

Review 3.  Short-term synaptic plasticity.

Authors:  Robert S Zucker; Wade G Regehr
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

4.  Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.

Authors:  Anne-Sophie Rolland; Maria-Trinidad Herrero; Virginia Garcia-Martinez; Merle Ruberg; Etienne C Hirsch; Chantal François
Journal:  Brain       Date:  2007-01       Impact factor: 13.501

5.  Bidirectional alterations in cerebellar synaptic transmission of tottering and rolling Ca2+ channel mutant mice.

Authors:  Kaori Matsushita; Minoru Wakamori; Im Joo Rhyu; Tatsuo Arii; Sen-Ichi Oda; Yasuo Mori; Keiji Imoto
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

Review 6.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

7.  Calcium control of transmitter release at a cerebellar synapse.

Authors:  I M Mintz; B L Sabatini; W G Regehr
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

8.  Factors in the genetic background suppress the engrailed-1 cerebellar phenotype.

Authors:  Natalie A Bilovocky; Rita R Romito-DiGiacomo; Crystal L Murcia; Stephen M Maricich; Karl Herrup
Journal:  J Neurosci       Date:  2003-06-15       Impact factor: 6.167

9.  A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl.

Authors:  Leann P Quinn; Marion J Perren; Kim T Brackenborough; Peter L Woodhams; Martin Vidgeon-Hart; Helen Chapman; Menelas N Pangalos; Neil Upton; David J Virley
Journal:  J Neurosci Methods       Date:  2007-04-06       Impact factor: 2.390

Review 10.  Influence of parallel fiber-Purkinje cell synapse formation on postnatal development of climbing fiber-Purkinje cell synapses in the cerebellum.

Authors:  K Hashimoto; T Yoshida; K Sakimura; M Mishina; M Watanabe; M Kano
Journal:  Neuroscience       Date:  2008-12-31       Impact factor: 3.590

View more
  25 in total

1.  Altered short-term synaptic plasticity and reduced muscle strength in mice with impaired regulation of presynaptic CaV2.1 Ca2+ channels.

Authors:  Evanthia Nanou; Jin Yan; Nicholas P Whitehead; Min Jeong Kim; Stanley C Froehner; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

2.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.

Authors:  Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

3.  Abnormal synaptic Ca(2+) homeostasis and morphology in cortical neurons of familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Michal Arbel-Ornath; Nilufer Yalcin; Esther S Yu; Kishore V Kuchibhotla; Izumi Yuzawa; Eloise Hudry; Carli R Willard; Mihail Climov; Fatmagul Keles; Arianna M Belcher; Buse Sengul; Andrea Negro; Isaac A Rosen; Andrea Arreguin; Michel D Ferrari; Arn M J M van den Maagdenberg; Brian J Bacskai; Cenk Ayata
Journal:  Ann Neurol       Date:  2015-07-06       Impact factor: 10.422

4.  Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.

Authors:  Akira Inagaki; C Andrew Frank; Yuriy M Usachev; Morris Benveniste; Amy Lee
Journal:  Neuron       Date:  2014-01-08       Impact factor: 17.173

5.  CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms.

Authors:  Lena Damaj; Alexis Lupien-Meilleur; Anne Lortie; Émilie Riou; Luis H Ospina; Louise Gagnon; Catherine Vanasse; Elsa Rossignol
Journal:  Eur J Hum Genet       Date:  2015-03-04       Impact factor: 4.246

Review 6.  Pathway-driven discovery of epilepsy genes.

Authors:  Jeffrey Noebels
Journal:  Nat Neurosci       Date:  2015-02-24       Impact factor: 24.884

7.  The first knockin mouse model of episodic ataxia type 2.

Authors:  Samuel J Rose; Lisa H Kriener; Ann K Heinzer; Xueliang Fan; Robert S Raike; Arn M J M van den Maagdenberg; Ellen J Hess
Journal:  Exp Neurol       Date:  2014-08-08       Impact factor: 5.330

8.  Seizing Control: From Current Treatments to Optogenetic Interventions in Epilepsy.

Authors:  Anh D Bui; Allyson Alexander; Ivan Soltesz
Journal:  Neuroscientist       Date:  2016-07-09       Impact factor: 7.519

Review 9.  Epilepsy and brain channelopathies from infancy to adulthood.

Authors:  Emanuele Bartolini; Roberto Campostrini; Lorenzo Kiferle; Silvia Pradella; Eleonora Rosati; Krishna Chinthapalli; Pasquale Palumbo
Journal:  Neurol Sci       Date:  2019-12-14       Impact factor: 3.307

Review 10.  Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.

Authors:  Juan M Pascual; Gabriel M Ronen
Journal:  Pediatr Neurol       Date:  2015-08-10       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.